Kevin Matthews joined Isogenica in October 2009, prior to which he was CEO of Oxonica plc (2001-2009), one of the UK’s leading nanotechnology businesses. Kevin is also a non-executive director and chairman of the remuneration committee of Elementis plc, a UK FTSE listed international speciality chemicals business. He is also chairman of the UK’s Nanotechnology Knowledge Transfer Network. Kevin has a DPhil in chemistry from Oxford and after an initial spell in research has spent his career taking new technologies to market. In the process he has become very familiar with the challenges of financing, technology development and protection, and commercialisation of new products both through direct sales and licensing across a broad range of industries including pharmaceutical, biotech, medical diagnostics, cosmetics and industrial materials.